VentriPoint Diagnostics Ltd. VPTDF
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -2.13% | 354.84% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.13% | 354.84% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -2.13% | 354.84% | |||
| SG&A Expenses | -2.09% | -33.69% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.08% | -28.80% | |||
| Operating Income | 2.08% | 31.05% | |||
| Income Before Tax | 2.08% | -171.78% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 2.08% | -242.71% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2.08% | -242.71% | |||
| EBIT | 2.08% | 31.05% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 0.00% | -188.89% | |||
| Normalized Basic EPS | 6.25% | 36.00% | |||
| EPS Diluted | 0.00% | -188.89% | |||
| Normalized Diluted EPS | 6.25% | 36.00% | |||
| Average Basic Shares Outstanding | 0.00% | 11.15% | |||
| Average Diluted Shares Outstanding | 0.00% | 11.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||